See more : Lanner Electronics Inc. (6245.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Delivra Health Brands Inc. (DHB.V) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Delivra Health Brands Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- JD Food Public Company Limited (JDF.BK) Income Statement Analysis – Financial Results
- Tekno S.A. Indústria e Comércio (TKNO4.SA) Income Statement Analysis – Financial Results
- Dream Office Real Estate Investment Trust (DRETF) Income Statement Analysis – Financial Results
- Kukje Pharma Co., Ltd. (002720.KS) Income Statement Analysis – Financial Results
- Investcorp India Acquisition Corp (IVCAU) Income Statement Analysis – Financial Results
Delivra Health Brands Inc. (DHB.V)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://delivrahealthbrands.com
About Delivra Health Brands Inc.
Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.38M | 9.79M | 8.14M | 7.96M | 7.78M | 5.98M | 725.98K | 75.95K | 0.00 |
| Cost of Revenue | 5.98M | 6.30M | 7.65M | 8.25M | 9.40M | 4.31M | 3.47M | 1.88M | 0.00 |
| Gross Profit | 6.40M | 3.49M | 485.00K | -297.00K | -1.62M | 1.68M | -2.75M | -1.80M | 0.00 |
| Gross Profit Ratio | 51.70% | 35.68% | 5.96% | -3.73% | -20.77% | 28.03% | -378.37% | -2,371.33% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 72.00K | 179.00K | 100.00K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.25M | 4.08M | 4.89M | 7.89M | 12.42M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.55M | 775.00K | 1.60M | 1.01M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.80M | 4.86M | 6.50M | 8.89M | 13.90M | 19.77M | 11.45M | 5.02M | 46.25K |
| Other Expenses | 1.31M | 1.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.11M | 4.86M | 6.50M | 8.96M | 14.08M | 19.87M | 11.45M | 5.02M | 46.25K |
| Cost & Expenses | 13.09M | 11.15M | 14.15M | 17.22M | 23.47M | 24.18M | 14.92M | 6.89M | 46.25K |
| Interest Income | 0.00 | 0.00 | 0.00 | 41.00K | 0.00 | 0.00 | 14.50K | 24.97K | 0.00 |
| Interest Expense | 169.00K | 250.00K | 635.00K | 0.00 | 799.00K | 3.00K | 1.90M | 149.39K | 0.00 |
| Depreciation & Amortization | 1.31M | 1.33M | 2.12M | 2.22M | 2.34M | 879.00K | 456.79K | 1.10M | 0.00 |
| EBITDA | 2.35M | 1.40M | -4.26M | -7.04M | -55.40M | -25.40M | -10.25M | -7.19M | -46.25K |
| EBITDA Ratio | 19.02% | -0.34% | -47.83% | -88.54% | -171.58% | -289.49% | -1,892.22% | -7,533.40% | 0.00% |
| Operating Income | -710.00K | -1.36M | -6.01M | -9.26M | -15.69M | -18.20M | -14.19M | -6.82M | -46.25K |
| Operating Income Ratio | -5.74% | -13.92% | -73.87% | -116.39% | -201.64% | -304.18% | -1,955.14% | -8,976.13% | 0.00% |
| Total Other Income/Expenses | 1.59M | 1.18M | -599.00K | -13.41M | -1.31M | 73.00K | -2.01M | -1.62M | 0.00 |
| Income Before Tax | 876.00K | -184.00K | -7.01M | -22.67M | -58.54M | -26.28M | -12.61M | -8.44M | -46.25K |
| Income Before Tax Ratio | 7.08% | -1.88% | -86.12% | -284.97% | -752.25% | -439.35% | -1,736.52% | -11,110.24% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 5.87M | 21.32M | 1.57M | 2.00 | -4.00 | 0.00 |
| Net Income | 876.00K | -184.00K | -7.01M | -28.54M | -79.86M | -27.85M | -12.61M | -8.44M | -46.25K |
| Net Income Ratio | 7.08% | -1.88% | -86.12% | -358.70% | -1,026.18% | -465.60% | -1,736.52% | -11,110.24% | 0.00% |
| EPS | 0.00 | 0.00 | -0.03 | -0.13 | -0.37 | -0.15 | -0.11 | -0.16 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | -0.03 | -0.13 | -0.37 | -0.15 | -0.11 | -0.16 | -0.02 |
| Weighted Avg Shares Out | 285.66M | 252.62M | 252.62M | 225.96M | 214.64M | 179.77M | 120.06M | 53.80M | 2.29M |
| Weighted Avg Shares Out (Dil) | 285.66M | 252.62M | 252.62M | 225.96M | 214.64M | 179.77M | 120.06M | 53.80M | 2.29M |
Source: https://incomestatements.info
Category: Stock Reports